These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 37216734)

  • 1. Successful treatment of advanced squamous cell carcinoma arising from mature cystic teratoma of the ovary with homologous recombination deficiency: A case report.
    Tamura R; Yamaguchi M; Kitani Y; Nishikawa N; Kawasaki T; Kikuchi A
    Int J Surg Case Rep; 2023 Jun; 107():108329. PubMed ID: 37216734
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Squamous cell carcinoma arising from a mature cystic teratoma of the ovary: Successful treatment with carboplatin, paclitaxel, and bevacizumab.
    Fukase M; Ohta T; Watanabe N; Suzuki Y; Seino M; Sudo T; Nagase S
    Gynecol Oncol Rep; 2020 Nov; 34():100632. PubMed ID: 32964091
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Olaparib: A Review as First-Line Maintenance Therapy in Advanced Ovarian Cancer.
    Paik J
    Target Oncol; 2021 Nov; 16(6):847-856. PubMed ID: 34623572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. FDA Approval Summary: Olaparib Monotherapy or in Combination with Bevacizumab for the Maintenance Treatment of Patients with Advanced Ovarian Cancer.
    Arora S; Balasubramaniam S; Zhang H; Berman T; Narayan P; Suzman D; Bloomquist E; Tang S; Gong Y; Sridhara R; Turcu FR; Chatterjee D; Saritas-Yildirim B; Ghosh S; Philip R; Pathak A; Gao JJ; Amiri-Kordestani L; Pazdur R; Beaver JA
    Oncologist; 2021 Jan; 26(1):e164-e172. PubMed ID: 33017510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mature Cystic Teratoma of the Ovary Transforms into Squamous Cell Carcinoma: A Case Report.
    Jeong CH
    J Menopausal Med; 2023 Dec; 29(3):146-149. PubMed ID: 38230600
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical significance of combined use of macrophage colony-stimulating factor and squamous cell carcinoma antigen as a selective diagnostic marker for squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Suzuki M; Tamura N; Kobayashi H; Ohwada M; Terao T; Sato I
    Gynecol Oncol; 2000 Jun; 77(3):405-9. PubMed ID: 10831350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Squamous cell carcinoma in mature cystic teratoma of the ovary induced by human papillomavirus 16 infection: A case report and literature review.
    Shi Z; Yang L; Bian C
    Medicine (Baltimore); 2022 Sep; 101(38):e30667. PubMed ID: 36197169
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Chiang AJ; La V; Peng J; Yu KJ; Teng NN
    Int J Gynecol Cancer; 2011 Apr; 21(3):466-74. PubMed ID: 21430455
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Driver Mutational Landscape of Ovarian Squamous Cell Carcinomas Arising in Mature Cystic Teratoma.
    Cooke SL; Ennis D; Evers L; Dowson S; Chan MY; Paul J; Hirschowitz L; Glasspool RM; Singh N; Bell S; Day E; Kochman A; Wilkinson N; Beer P; Martin S; Millan D; Biankin AV; McNeish IA;
    Clin Cancer Res; 2017 Dec; 23(24):7633-7640. PubMed ID: 28954785
    [No Abstract]   [Full Text] [Related]  

  • 10. Olaparib treatment for platinum-sensitive relapsed ovarian cancer by BRCA mutation and homologous recombination deficiency status: Phase II LIGHT study primary analysis.
    Cadoo K; Simpkins F; Mathews C; Liu YL; Provencher D; McCormick C; ElNaggar AC; Altman AD; Gilbert L; Black D; Kabil N; Bennett J; Munley J; Aghajanian C
    Gynecol Oncol; 2022 Sep; 166(3):425-431. PubMed ID: 35803835
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A rare case of microinvasive squamous cell carcinoma arising in mature cystic teratoma of the ovary.
    Togami S; Kawamura T; Kamio M; Douchi T
    Eur J Gynaecol Oncol; 2016; 37(3):420-2. PubMed ID: 27352578
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Large cell neuroendocrine carcinoma arising in mature cystic teratoma: a case report and review of the literature.
    Miyamoto M; Takano M; Goto T; Kato M; Sasaki N; Furuya K
    Eur J Gynaecol Oncol; 2012; 33(4):414-8. PubMed ID: 23091901
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Homologous Recombination Repair Gene Mutations to Predict Olaparib Plus Bevacizumab Efficacy in the First-Line Ovarian Cancer PAOLA-1/ENGOT-ov25 Trial.
    Pujade-Lauraine E; Brown J; Barnicle A; Wessen J; Lao-Sirieix P; Criscione SW; du Bois A; Lorusso D; Romero I; Petru E; Yoshida H; Vergote I; Colombo N; Hietanen S; Provansal M; Schmalfeldt B; Pignata S; Martín Lorente C; Berton D; Runnebaum IB; Ray-Coquard I
    JCO Precis Oncol; 2023 Jan; 7():e2200258. PubMed ID: 36716415
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Radiotherapy for persistent malignant transformation from mature cystic teratoma of the ovary.
    Yoshida K; Kajiyama H; Utsumi F; Mitsui H; Shibata K; Kikkawa F
    J Obstet Gynaecol Res; 2016 May; 42(5):584-588. PubMed ID: 26889642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Alternative academic approaches for testing homologous recombination deficiency in ovarian cancer in the MITO16A/MaNGO-OV2 trial.
    Capoluongo ED; Pellegrino B; Arenare L; Califano D; Scambia G; Beltrame L; Serra V; Scaglione GL; Spina A; Cecere SC; De Cecio R; Normanno N; Colombo N; Lorusso D; Russo D; Nardelli C; D'Incalci M; Llop-Guevara A; Pisano C; Baldassarre G; Mezzanzanica D; Artioli G; Setaro M; Tasca G; Roma C; Campanini N; Cinieri S; Sergi A; Musolino A; Perrone F; Chiodini P; Marchini S; Pignata S
    ESMO Open; 2022 Oct; 7(5):100585. PubMed ID: 36156447
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Detection of human papillomavirus in squamous cell carcinoma arising from dermoid cysts.
    Chiang AJ; Chen DR; Cheng JT; Chang TH
    Taiwan J Obstet Gynecol; 2015 Oct; 54(5):559-66. PubMed ID: 26522111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Diagnosis of squamous cell carcinoma arising from mature cystic teratoma of the ovary.
    Kikkawa F; Nawa A; Tamakoshi K; Ishikawa H; Kuzuya K; Suganuma N; Hattori S; Furui K; Kawai M; Arii Y
    Cancer; 1998 Jun; 82(11):2249-55. PubMed ID: 9610706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Homologous recombination deficiency (HRD) signature-3 in ovarian and uterine carcinosarcomas correlates with preclinical sensitivity to Olaparib, a poly (adenosine diphosphate [ADP]- ribose) polymerase (PARP) inhibitor.
    Tymon-Rosario JR; Manara P; Manavella DD; Bellone S; Hartwich TMP; Harold J; Yang-Hartwich Y; Zipponi M; Choi J; Jeong K; Mutlu L; Yang K; Altwerger G; Menderes G; Ratner E; Huang GS; Clark M; Andikyan V; Azodi M; Schwartz PE; Alexandrov LB; Santin AD
    Gynecol Oncol; 2022 Jul; 166(1):117-125. PubMed ID: 35599167
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Case report: Response to platinum agents and poly (adenosine diphosphate-ribose) polymerase inhibitor in a patient with BRCA1 c.5096G>A (R1699Q) intermediate-risk variant.
    Saito A; Tanioka M; Hirata M; Watanabe T; Odaka Y; Shimoi T; Sudo K; Noguchi E; Ishikawa M; Yonemori K
    Cancer Treat Res Commun; 2022; 32():100587. PubMed ID: 35696850
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Homologous recombination deficiency real-time clinical assays, ready or not?
    Fuh K; Mullen M; Blachut B; Stover E; Konstantinopoulos P; Liu J; Matulonis U; Khabele D; Mosammaparast N; Vindigni A
    Gynecol Oncol; 2020 Dec; 159(3):877-886. PubMed ID: 32967790
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.